about
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteersmiRNAs as potential biomarkers in early breast cancer detection following mammographyEmerging role of cell polarity proteins in breast cancer progression and metastasisBreast cancer risk accumulation starts early: prevention must alsoThe rebel angel: mutant p53 as the driving oncogene in breast cancer.StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasionAtypical hyperplasia of the breast--risk assessment and management options.Pseudo-HE images derived from CARS/TPEF/SHG multimodal imaging in combination with Raman-spectroscopy as a pathological screening toolUnderstanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectivesInhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.SMAD4 is a potential prognostic marker in human breast carcinomas.Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapseThe dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer.Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer.Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteinsAge-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young womenExpression of Cancer/Testis genes in ductal carcinoma in situ and benign lesions of the breast.Comprehensive proteome quantification reveals NgBR as a new regulator for epithelial-mesenchymal transition of breast tumor cellsExpression of NgBR is highly associated with estrogen receptor alpha and survivin in breast cancer.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.The overexpression membrane type 1 matrix metalloproteinase is associated with the progression and prognosis in breast cancer.Altered Endoplasmic Reticulum Calcium Pump Expression during Breast Tumorigenesis.ABCG2 is associated with HER-2 expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma.Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin ChemosensitivityFlat epithelial atypia and risk of breast cancer: A Mayo cohort study.Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.Subgross morphology, the sick lobe hypothesis, and the success of breast conservationHow can grafted breast cancer models be optimized?Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer.Down-regulation of ANAPC13 and CLTCL1: Early Events in the Progression of Preinvasive Ductal Carcinoma of the Breast.SMAD4 expression in breast ductal carcinoma correlates with prognosis.Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancerThe effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches.Breast cancer risk and imprinting methylation in blood.miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast.
P2860
Q21195201-9ED048D5-8BA0-49E4-A845-F177D8B62B64Q26773094-C7B89032-E040-491F-8C63-2AF6DAC94194Q26851833-25AB7EFA-833A-46EC-BA13-26537C767F44Q26851902-255EA5B8-022C-442B-AB88-FF21083398BBQ27686765-E63E578C-361D-4610-8FEA-634C042C23A3Q28386295-9DA1E804-4B3A-4AFB-93B3-E8C484146C30Q30301033-132C0B54-40FE-4EFC-AC65-C6175914D4A8Q30378079-045F61BE-E228-4807-921C-F4DC2FE766E5Q30408300-88167732-9535-44AA-8CC2-22504C23D9A6Q30570945-68112D6A-3C88-4985-9349-CCE856807F35Q33717428-0A1D248D-3BD9-418A-9EDA-F72D528E992BQ33804529-9944F2C9-FDD6-4740-B624-D9D8AE9B42C3Q34079958-3256766F-1A34-40B5-9C0A-716D4E6B19A9Q34125932-DD58218B-BB49-4607-BAB9-8704A772A347Q34178564-6AB6F552-6D3F-457C-890C-9614505463E0Q34444593-8CF1B254-25C5-42A0-89F9-97EE5979262AQ34460058-75F01D5B-9D68-4ADD-B72E-6A32770C9964Q34737360-FC521FF9-94B2-4505-B39E-B1F842A94414Q34971907-D477F42B-A973-40CC-B635-3DFB2116D360Q35032720-2B35CB06-059F-4AED-92B6-688E34D6FE93Q35040780-FF1E5330-A529-4DC1-B52C-5FF2FD126B60Q35094742-1F91FEB6-651C-4283-A63A-62FBE7B613A3Q35137808-B6DCEA37-9636-44D3-B1FA-0FF145F01A9BQ35155456-AEEDEE1D-EEE3-4B87-BCE3-58F477FA4041Q35318963-DEE25B89-69B4-41F5-9C4B-06038C49D45DQ35556517-F0ED4C35-EB9F-4BFB-BE63-990EA6174FC7Q35582531-A185661D-3080-4010-B090-14967C126A72Q35655229-5F3A165D-272C-4F8C-9461-260CD32EF551Q35684422-65500C51-334E-4451-BD95-677B033BB7FBQ35760911-2EC67BF1-2D87-4772-85E1-95A4C4322275Q35827623-44D11CDD-17C4-4539-B811-0BD8BCD1B654Q35882253-A2A9D9CB-844E-407E-97A9-BBDD01C1EADAQ35944076-AF5C1523-AD8C-4337-AC11-09BE54CF98EFQ35945945-E147B0B7-293C-469A-A770-858D48739A1EQ35949533-C918E7A5-9BC5-4B00-B670-7ADF46CBD49EQ36023456-4FC8B71C-81AA-4B8E-93E9-164AAC14BF11Q36027913-787A585E-70A1-4C2B-B5A7-3BFB97828410Q36191985-06269C37-A2B8-44CD-B4EE-5AC8DF232EA8Q36240628-1C4E922C-354E-4FC4-8EE9-B7CC3C870A30Q36300973-80F5A284-1427-4C16-B09F-DC6DDF03BC9E
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The molecular pathology of breast cancer progression.
@ast
The molecular pathology of breast cancer progression.
@en
The molecular pathology of breast cancer progression.
@nl
type
label
The molecular pathology of breast cancer progression.
@ast
The molecular pathology of breast cancer progression.
@en
The molecular pathology of breast cancer progression.
@nl
prefLabel
The molecular pathology of breast cancer progression.
@ast
The molecular pathology of breast cancer progression.
@en
The molecular pathology of breast cancer progression.
@nl
P2860
P356
P1476
The molecular pathology of breast cancer progression.
@en
P2093
Alessandro Bombonati
Dennis C Sgroi
P2860
P304
P356
10.1002/PATH.2808
P577
2010-11-16T00:00:00Z